drugset / Trial / NCT07699445
The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression
Phase 4
Not yet recruiting
25 enrolled
Massachusetts General Hospital
Johnson and Johnson Medical · collab
NaSingle-groupOpen-labelTreatment
Summary
This research study examines how a medication called lumateperone may affect mood symptoms, and inflammation in adults with bipolar disorder over approximately 6 weeks. An MRI scan to calculate biological age of the brain will also be obtained at the start of the study.
Timeline
- Start
- 2026-07-31
- Primary completion
- 2028-01-31
- Completion
- 2028-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lumateperone | Small molecule | 42 mg | Oral |